Joint Press Release by WACKER and SCHOTT - SCHOTT WACKER Solar to produce multicrystalline silicon wafers for solar cells - 370 million investment to create at least 700 new jobs - Production start-up in 2007 - Capacity expansion phased to reach 1 gigawatt per year by 2012 ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. companies Munich / Mainz ...
Sydney, Australia (ots/PRNewswire) - New data from two new studies of Viramune(R) (nevirapine) were presented at the 4th International AIDS Society (IAS) in Sydney, Australia. Results from an extended three-year follow-up analysis of the 2NN study demonstrated that HIV-positive patients taking ...
Ingelheim, Germany (ots/PRNewswire) - - Trial to compare newest protease inhibitors in treatment-experienced patients with resistance to more than one PI Boehringer Ingelheim GmbH announced today that enrollment of the POTENT study will begin in August 2007. POTENT will compare the efficacy and safety ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. establishment of joint ventures 20.07.2007 Munich / Mainz, 07/20/2007 - Wacker Chemie AG and SCHOTT Solar GmbH, a subsidiary of SCHOTT AG, intend to set up a joint venture to produce silicon ...
- First commercial-scale production of granular polysilicon for the solar industry - New facility's nominal capacity set for 650 metric tons per year, with capex of approx. 40 million - New production technology enables processing advantages and boosts energy efficiency ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of ...
Ingelheim, Germany (ots/PRNewswire) - Boehringer Ingelheim GmbH announced today that it has begun to enroll patients in the SPRING study. The SPRING study will be one of the largest racially and gender diverse international studies of highly treatment-experienced HIV-1 infected patients. The trial ...
- DECISION TO EXPAND NOMINAL PRODUCTION CAPACITY BY ANOTHER 7,000 METRIC TONS PER YEAR - CAPITAL EXPENDITURES OF ABOUT 400 MILLION ARE ESTIMATED TO CREATE SOME 200 JOBS - CEO PETER-ALEXANDER WACKER: CAPACITY EXPANSION REFLECTS STRONG CUSTOMER DEMAND ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. companies Dettingen/Erms (euro adhoc) - Stuttgart, Dettingen/Erms, May 25, 2007 +++ SDAX-listed ElringKlinger AG will pay a dividend of EUR 1.25 (1.00) per share for the 2006 fiscal year. Attended by more than 600 shareholders, today's Annual General ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 16.05.2007 AD HOC ANNOUNCEMENT PURSUANT TO SECTION 15 WPHG LPKF wins additional solar orders Garbsen/Suhl 16 May 2007 - LPKF SolarQuipment GmbH, a subsidiary of LPKF Laser & Electronics AG, has won two more orders for AllegroTM solar ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 3-month report 16.05.2007 Sales +7.9% to EUR 89.2 million Net result +11.2% to EUR 6.4 million Positive outlook for the full year 2007 Good economic conditions in the first quarter ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 3-month report 10.05.2007 > Operating result up by 13% > EBIT growth of 19% > Consolidated net income after minority interests grows by 21% > Order backlog up 12% on previous ...
Ingelheim, Germany (ots/PRNewswire) - - Trial to Compare Efficacy and Safety of Viramune(R) (Nevirapine) Versus Atazanavir/Ritonavir in Treatment-Naive Patients Boehringer Ingelheim GmbH announced today that it has initiated and begun enrollment of patients in the ArTEN trial, which will compare the efficacy and safety of Viramune(R) (nevirapine), ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 3-month report 09.05.2007 Basler: Strong Components Business, Weaker Start for Systems Business . First quarter 2007 turnover up by 14% over first quarter 2006 . Record incoming orders for ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. annual report 30.03.2007 BWT strengthens market leadership in Europe Growth in sales and earnings New potentials in Point-of-Use and fuel cell markets The final ...
Ingelheim, Germany (ots/PRNewswire) - Long-term data from the Nevirapine/Efavirenz/Abacavir (NEFA) study demonstrate that patients who switched from a protease inhibitor-based regimen to a non-nucleoside reverse transcriptase inhibitor-based regimen containing Viramune(R) (nevirapine) or efavirenz achieved comparable efficacy and safety to their previous regimen ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 15.01.2007 AD HOC ANNOUCEMENT PURSUANT TO Section15 WPHG LPKF enters solar technology market LPKF Laser & Electronics AG in Garbsen/Germany now sells laser systems for ...
- Leading provider of synchronization software is partnering with asknet for its Internet distribution services ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Karlsruhe (euro adhoc) - Karlsruhe (Germany), December 20, 2006 - asknet AG (ISIN: DE0005173306), one of the leading providers of outsourcing ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 17.11.2006 Sales +12.2% to EUR 262.8 million EBIT +20.2% to EUR 25.7 million With sales growth of 19.0% and a 70.2% year-on-year improvement in EBIT, BWT - Best Water ...
Glasgow, Scotland, November 15 (ots/PRNewswire) - - New Sub-analyses Provide Insight into Treatment Benefits New data from the combined RESIST studies (RESIST-1 and RESIST-2) show that Aptivus(R) (tipranavir), used with ritonavir (tipranavir/r) as part of combination antiretroviral therapy, continued to ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 08.11.2006 Basler shows sustained growth and sets a key course for the future . Nine month results: turnover 14% up and net earnings 30% up on same period last year . Strong third quarter ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 01.09.2006 Basler Enters Solar Market Basler AG, one of the leading companies in the field of Vision Technology (the technology of machine-based vision), is expanding its business activities in ...
Toronto (ots/PRNewswire) - New data on tipranavir oral solution from a Phase II dose finding study in 115 HIV-1 infected children aged 2 to 18 years were announced today at the 16th International AIDS Conference (IAC) in Toronto, Canada. Results from this 48-week analysis show that patients achieved virologic ...
- DECISION TO EXPAND NOMINAL PRODUCTION CAPACITY BY ANOTHER 4,500 METRIC TONS PER YEAR - SOLAR-SECTOR DEMAND FOR POLYSILICON EXPECTED TO SHOW FURTHER RAPID GROWTH - CAPITAL EXPENDITURES OF ABOUT 300 MILLION ARE ESTIMATED TO CREATE SOME 270 JOBS - CEO PETER-ALEXANDER WACKER: WEVE REACHED ANOTHER MILESTONE IN OUR GROUPS LONG-TERM STRATEGY FOR PROFITABLE ...
Ludwigshafen, Germany (ots/PRNewswire) - - BASF CEO Hambrecht: 'We started the integration process.' BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) today announced the successful completion of its acquisition of Engelhard Corporation (NYSE: EC). "Together with the Engelhard team we have started the integration process in which our customers continue to be the key priority," ...
Ludwigshafen, Germany (ots/PRNewswire) - - BASF Announces Completion of Subsequent Offering Period BASF Aktiengesellschaft (Frankfurt: BAS; NYSE: BF [ADR]; LSE: BFA; SWX: AN) today announced the completion of the subsequent offering period for the outstanding shares of Engelhard. As of 8:00 p.m. New York City time on June 8, 2006, a total of 113,489,680 shares, representing more than 90% of Engelhard's (NYSE: ...
Ludwigshafen, Germany (ots/PRNewswire) - - BASF-CEO Hambrecht: 'Special day for BASF and Engelhard, more innovative solutions for customers.' - Subsequent offering period to expire on June 8, 2006 BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) today announced the expiration of its initial tender offer period to purchase all of the outstanding shares of Engelhard Corporation ...
Ludwigshafen, Germany (ots/PRNewswire) - - Engelhard Recommends That Engelhard's Shareholders Accept BASF's Offer - BASF CEO Hambrecht: "Crucial step towards acquisition of Engelhard." BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) announced today that it signed a definitive agreement with Engelhard Corporation (NYSE: EC). According to the agreement, Engelhard will recommend that Engelhard shareholders tender their shares to BASF ...
Ludwigshafen, Germany (ots/PRNewswire) - BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) today announced that Institutional Shareholder Services (ISS) has recommended that Engelhard's shareholders vote for BASF's five nominees for election to Engelhard's Board of Directors at the June 2 Annual Shareholders' Meeting. ISS is a ...
Ludwigshafen, Germany (ots/PRNewswire) - - BASF CEO Hambrecht: 'This is our last, best and final offer.' BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) today announced that it has raised its all-cash offer for Engelhard Corporation (NYSE: EC) to US$39 per share from its previous offer of US$38 per share. "We are confident that Engelhard's shareholders will recognize the superior ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 19.05.2006 - Sales +8.2% to EUR 82.6 million - EBIT +10.4% reaching EUR 8.4 million With a sales performance which exceeded expectations and a year-on-year increase in EBIT of more than 20 % ...
